Investigational new drug
Investigational New Drug (IND) is a term used in the pharmaceutical industry to describe a new drug that is under investigation but has not yet been approved by the Food and Drug Administration (FDA) for general use. The IND application is the means by which a pharmaceutical company obtains permission to start human clinical trials and to ship an experimental drug across state lines before a marketing application for the drug has been approved.
Overview[edit | edit source]
The IND application is part of the FDA's drug approval process, which includes three phases of clinical trials designed to test the safety, effectiveness, and side effects of new drugs. The IND application must include data from preclinical testing and animal studies, as well as a plan for testing the drug in humans.
Preclinical Testing[edit | edit source]
Before a company can submit an IND application, it must conduct extensive preclinical testing. This includes laboratory and animal studies to evaluate the safety and effectiveness of the drug. The results of these studies are used to justify the proposed clinical trials in humans.
Clinical Trials[edit | edit source]
Once the IND application is approved, the company can begin clinical trials. These are divided into three phases:
- Phase I trials test the drug in a small group of healthy volunteers to evaluate its safety and dosage.
- Phase II trials involve a larger group of patients and are designed to assess the drug's effectiveness and further evaluate its safety.
- Phase III trials are conducted in large groups of patients to confirm the drug's effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug to be used safely.
Post-Marketing Surveillance[edit | edit source]
After a drug has been approved by the FDA and is on the market, it is subject to post-marketing surveillance. This is a phase IV clinical trial that monitors the long-term effects of the drug in the general population.
See Also[edit | edit source]
| Investigational new drug Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
